Armstrong Ind (AWI) Investors: RBC Capital Maintains “Hold” Rating, Sees $55.0/Share; Akorn, Inc. (AKRX) Had 5 Bulls

November 15, 2017 - By Migdalia James

Among 15 analysts covering Armstrong World Industries (NYSE:AWI), 5 have Buy rating, 2 Sell and 8 Hold. Therefore 33% are positive. Armstrong World Industries has $66 highest and $43 lowest target. $52.50’s

average target is 4.69% above currents $50.15 stock price. Armstrong World Industries had 28 analyst reports since July 31, 2015 according to SRatingsIntel. The firm has “Neutral” rating given on Tuesday, October 6 by Goldman Sachs. The stock has “Sector Weight” rating by KeyBanc Capital Markets on Thursday, January 5. On Wednesday, August 5 the stock rating was maintained by Deutsche Bank with “Buy”. The company was reinitiated on Friday, December 16 by Macquarie Research. The rating was maintained by Citigroup on Friday, October 20 with “Neutral”. RBC Capital Markets maintained the shares of AWI in report on Monday, October 9 with “Hold” rating. As per Wednesday, January 27, the company rating was upgraded by BB&T Capital. The firm has “Neutral” rating by Piper Jaffray given on Monday, May 16. JP Morgan maintained it with “Neutral” rating and $50 target in Tuesday, February 23 report. KeyBanc Capital Markets maintained the stock with “Hold” rating in Tuesday, October 24 report.

Among 16 analysts covering Akorn Inc (NASDAQ:AKRX), 5 have Buy rating, 2 Sell and 9 Hold. Therefore 31% are positive. Akorn Inc had 36 analyst reports since July 21, 2015 according to SRatingsIntel. The firm earned “Hold” rating on Friday, August 5 by Deutsche Bank. Nomura upgraded the shares of AKRX in report on Wednesday, December 2 to “Buy” rating. The firm has “Overweight” rating given on Thursday, September 15 by Piperjaffray. Piper Jaffray maintained the shares of AKRX in report on Tuesday, August 8 with “Hold” rating. JMP Securities initiated Akorn, Inc. (NASDAQ:AKRX) on Wednesday, September 9 with “Market Perform” rating. Susquehanna maintained Akorn, Inc. (NASDAQ:AKRX) rating on Wednesday, March 23. Susquehanna has “Neutral” rating and $30 target. As per Wednesday, March 16, the company rating was maintained by Leerink Swann. Piper Jaffray maintained it with “Hold” rating and $34.0 target in Friday, September 15 report. The firm has “Market Perform” rating given on Tuesday, August 2 by Raymond James. RBC Capital Markets maintained Akorn, Inc. (NASDAQ:AKRX) rating on Friday, February 12. RBC Capital Markets has “Outperform” rating and $37 target. See Akorn, Inc. (NASDAQ:AKRX) latest ratings:

05/11/2017 Broker: RBC Capital Markets Rating: Hold New Target: $34.0 Maintain
27/10/2017 Broker: Jefferies Rating: Hold New Target: $34.0 Maintain
20/10/2017 Broker: Piper Jaffray Rating: Hold New Target: $34.0 Maintain
02/10/2017 Broker: RBC Capital Markets Rating: Hold New Target: $34.0 Maintain
15/09/2017 Broker: Piper Jaffray Rating: Hold New Target: $34.0 Maintain
05/09/2017 Broker: Jefferies Rating: Hold New Target: $34.0 Maintain
01/09/2017 Broker: RBC Capital Markets Rating: Hold New Target: $34.0 Maintain
29/08/2017 Broker: Piper Jaffray Rating: Hold New Target: $34.0 Maintain
08/08/2017 Broker: Piper Jaffray Rating: Hold New Target: $34.0000 Maintain
30/07/2017 Broker: RBC Capital Markets Rating: Hold New Target: $34.0000 Maintain

It closed at $50.15 lastly. It is down 6.90% since November 15, 2016 and is uptrending. It has underperformed by 9.80% the S&P500.

Armstrong World Industries, Inc. is a global producer of ceiling systems. The company has market cap of $2.65 billion. The Firm owns and operates the Building Products (Ceilings) segment. It has a 18.84 P/E ratio. The Firm designs, makes and sells ceiling systems (primarily mineral fiber, fiberglass wool and metal) around the world.

Analysts await Armstrong World Industries Inc (NYSE:AWI) to report earnings on February, 26. They expect $0.70 EPS, up 55.56% or $0.25 from last year’s $0.45 per share. AWI’s profit will be $36.99M for 17.91 P/E if the $0.70 EPS becomes a reality. After $0.86 actual EPS reported by Armstrong World Industries Inc for the previous quarter, Wall Street now forecasts -18.60% negative EPS growth.

Investors sentiment decreased to 1.05 in Q2 2017. Its down 0.42, from 1.47 in 2017Q1. It turned negative, as 25 investors sold Armstrong World Industries Inc shares while 50 reduced holdings. 23 funds opened positions while 56 raised stakes. 58.76 million shares or 1.29% more from 58.01 million shares in 2017Q1 were reported. Moreover, Creative Planning has 0% invested in Armstrong World Industries Inc (NYSE:AWI). London Of Virginia invested in 2.96 million shares. Cubist Systematic Strategies Lc invested 0.03% in Armstrong World Industries Inc (NYSE:AWI). Winfield Associate accumulated 60 shares. Primecap Co Ca invested in 0% or 47,000 shares. Moreover, Cipher Cap Ltd Partnership has 0.04% invested in Armstrong World Industries Inc (NYSE:AWI). 1.85 million are owned by Blackrock. Adage Capital Prtnrs Ltd Co invested in 825,000 shares. Fiduciary Management Wi has 0.52% invested in Armstrong World Industries Inc (NYSE:AWI). Teachers Retirement Sys Of The State Of Kentucky, Kentucky-based fund reported 23,866 shares. Parametric Port Associates Ltd Liability Corporation invested in 215,730 shares or 0.01% of the stock. Intll Grp Inc Incorporated reported 0% in Armstrong World Industries Inc (NYSE:AWI). Northern Tru reported 238,723 shares. Manitoba – Canada-based Great West Life Assurance Can has invested 0% in Armstrong World Industries Inc (NYSE:AWI). Golden Gate Private Equity accumulated 2.32% or 98,550 shares.

It closed at $33.37 lastly. It is down 12.04% since November 15, 2016 and is uptrending. It has underperformed by 4.66% the S&P500.

Akorn Inc. , together with its subsidiaries, is a specialty generic pharmaceutical firm that develops, makes and markets generic and branded prescription pharmaceuticals, as well as private-label over-the-counter (OTC) consumer health products and animal health pharmaceuticals. The company has market cap of $4.17 billion. The Firm operates through two divisions: Prescription Pharmaceuticals and the Consumer Health. It has a 56.96 P/E ratio. The Prescription Pharmaceuticals segment consists of generic and branded prescription pharmaceuticals in a range of dosage forms, including sterile ophthalmics, injectables and inhalants and non-sterile oral liquids, topicals and nasal sprays and otics.

By

Echostar Corporation-Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


>